GlassScriptPhysician profile
Azuka Anyoku
NPI 1386747681
$734.13
in general payments reported to CMS, 2019-2025
16 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $64.11 · 2022: $12.57 · 2024: $152 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $98.85 | 2019-2025 | Verquvo |
| Opko Pharmaceuticals, LLC | $82.16 | 2024-2025 | Rayaldee |
| Novartis Pharmaceuticals Corporation | $70.11 | 2019-2025 | |
| Novo Nordisk INC | $67.53 | 2019-2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.57 | 2025 | Jardiance |
| Ani Pharmaceuticals, INC. | $53.43 | 2025 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $46.33 | 2019-2020 | |
| Abbvie INC. | $46.12 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $45.94 | 2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $37.42 | 2025 | Airsupra |
| Lilly USA, LLC | $28.60 | 2019 | |
| Almatica Pharma LLC | $22.83 | 2025 | Loreev Xr |
| Pfizer INC. | $22.58 | 2025 | |
| Bridgebio Pharma, INC. | $20.96 | 2025 | Attruby |
| Janssen Biotech, INC. | $18.13 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azuka Anyoku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.